A Long-Acting HIV Prevention Shot Has Promise, but Access Still Lags

Lenacapavir may make HIV prevention easier for many people, but the latest reporting shows a familiar gap: regulatory progress is moving faster than real-world supply.

Lenacapavir may make HIV prevention easier for many people, but the latest reporting shows a familiar gap: regulatory progress is moving faster than real-world supply.